CA Stock MarketDetailed Quotes

ONC Oncolytics Biotech Inc

Watchlist
  • 1.350
  • 0.0000.00%
15min DelayMarket Closed Aug 15 16:00 ET
103.76MMarket Cap-3552P/E (TTM)

Oncolytics Biotech Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
2.05%24.85M
-0.23%29.6M
8.63%34.91M
8.63%34.91M
23.54%39.98M
-27.72%24.35M
-24.85%29.67M
-22.11%32.14M
-22.11%32.14M
-32.70%32.36M
-Cash and cash equivalents
41.84%24.85M
86.51%29.6M
199.26%34.91M
199.26%34.91M
23.54%39.98M
-48.00%17.52M
-59.80%15.87M
-71.73%11.67M
-71.73%11.67M
-32.70%32.36M
Total current assets
-1.17%30.63M
-2.57%33.38M
6.98%38.17M
6.98%38.17M
18.67%45.34M
-21.35%31M
-21.30%34.26M
-20.53%35.68M
-20.53%35.68M
-25.95%38.21M
Non current assets
-Accumulated depreciation
----
----
-13.19%-695K
-13.19%-695K
----
----
----
-17.85%-614K
-17.85%-614K
----
-Long term equity investment
157.51%891K
150.79%948K
84.71%290K
84.71%290K
94.67%323K
80.12%346K
36.64%378K
-56.51%157K
-56.51%157K
-62.46%165.92K
-Including:Held to maturity investments
--848K
--623K
----
----
----
----
----
----
----
----
Regulatory assets
181.04%1.57M
-86.03%102K
-97.12%15K
-97.12%15K
26.80%630K
57.20%559K
614.17%730K
-39.84%521K
-39.84%521K
97.70%496.86K
Liabilities
Current liabilities
Current debt and capital lease obligation
69.17%225K
-5.29%179K
-38.43%133K
-38.43%133K
-35.22%191K
-59.74%133K
-38.53%189K
-26.53%216K
-26.53%216K
9.71%294.86K
-Current capital lease obligation
69.17%225K
-5.29%179K
-38.43%133K
-38.43%133K
-35.22%191K
-59.74%133K
-38.53%189K
-26.53%216K
-26.53%216K
9.71%294.86K
-accounts payable
----
----
-51.95%1.08M
-51.95%1.08M
--2.19M
--629K
----
279.12%2.25M
279.12%2.25M
----
-Total tax payable
7.70%7.62M
8.02%7.68M
1.93%7.02M
1.93%7.02M
2.27%7.05M
2.22%7.08M
1.44%7.11M
-2.88%6.89M
-2.88%6.89M
-3.85%6.9M
Current accrued expenses
----
----
78.11%2.49M
78.11%2.49M
--2.35M
--1.74M
----
0.29%1.4M
0.29%1.4M
----
Current liabilities
131.50%6.14M
66.18%4.1M
7.40%4.24M
7.40%4.24M
173.26%10.02M
4.20%2.65M
1.85%2.47M
46.65%3.95M
46.65%3.95M
35.33%3.67M
Non current liabilities
-Long term debt
157.51%891K
150.79%948K
84.71%290K
84.71%290K
94.67%323K
80.12%346K
36.64%378K
-56.51%157K
-56.51%157K
-62.46%165.92K
Non current accrued expenses
93.01%1.44M
62.86%1.37M
-0.77%647K
-0.77%647K
-0.23%752K
-10.56%744K
-7.76%840K
-33.20%652K
-33.20%652K
-24.64%753.71K
Total non current liabilities
41.44%13.76M
23.01%11.78M
3.92%11.26M
3.92%11.26M
61.62%17.07M
2.75%9.73M
1.55%9.58M
10.75%10.83M
10.75%10.83M
6.89%10.56M
Shareholders'equity
Share capital
5.11%434.55M
5.64%432.51M
6.65%430.91M
6.65%430.91M
7.73%428.83M
4.19%413.42M
3.26%409.41M
3.24%404.04M
3.24%404.04M
1.76%398.07M
-common stock
5.11%434.55M
5.64%432.51M
6.65%430.91M
6.65%430.91M
7.73%428.83M
4.19%413.42M
3.26%409.41M
3.24%404.04M
3.24%404.04M
1.76%398.07M
Additional paid-in capital
6.94%43.2M
5.75%42.69M
5.16%42.12M
5.16%42.12M
5.82%41.59M
4.09%40.39M
16.18%40.37M
17.24%40.05M
17.24%40.05M
18.43%39.3M
Gains losses not affecting retained earnings
30.32%722K
1.67%670K
-17.82%544K
-17.82%544K
-9.36%655K
22.23%554K
93.41%659K
70.62%662K
70.62%662K
77.79%722.63K
Total equity
0.32%32.07M
-1.64%34.75M
3.98%38.82M
3.98%38.82M
18.30%46.09M
-20.56%31.97M
-20.52%35.33M
-18.63%37.33M
-18.63%37.33M
-25.92%38.96M
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 2.05%24.85M-0.23%29.6M8.63%34.91M8.63%34.91M23.54%39.98M-27.72%24.35M-24.85%29.67M-22.11%32.14M-22.11%32.14M-32.70%32.36M
-Cash and cash equivalents 41.84%24.85M86.51%29.6M199.26%34.91M199.26%34.91M23.54%39.98M-48.00%17.52M-59.80%15.87M-71.73%11.67M-71.73%11.67M-32.70%32.36M
Total current assets -1.17%30.63M-2.57%33.38M6.98%38.17M6.98%38.17M18.67%45.34M-21.35%31M-21.30%34.26M-20.53%35.68M-20.53%35.68M-25.95%38.21M
Non current assets
-Accumulated depreciation ---------13.19%-695K-13.19%-695K-------------17.85%-614K-17.85%-614K----
-Long term equity investment 157.51%891K150.79%948K84.71%290K84.71%290K94.67%323K80.12%346K36.64%378K-56.51%157K-56.51%157K-62.46%165.92K
-Including:Held to maturity investments --848K--623K--------------------------------
Regulatory assets 181.04%1.57M-86.03%102K-97.12%15K-97.12%15K26.80%630K57.20%559K614.17%730K-39.84%521K-39.84%521K97.70%496.86K
Liabilities
Current liabilities
Current debt and capital lease obligation 69.17%225K-5.29%179K-38.43%133K-38.43%133K-35.22%191K-59.74%133K-38.53%189K-26.53%216K-26.53%216K9.71%294.86K
-Current capital lease obligation 69.17%225K-5.29%179K-38.43%133K-38.43%133K-35.22%191K-59.74%133K-38.53%189K-26.53%216K-26.53%216K9.71%294.86K
-accounts payable ---------51.95%1.08M-51.95%1.08M--2.19M--629K----279.12%2.25M279.12%2.25M----
-Total tax payable 7.70%7.62M8.02%7.68M1.93%7.02M1.93%7.02M2.27%7.05M2.22%7.08M1.44%7.11M-2.88%6.89M-2.88%6.89M-3.85%6.9M
Current accrued expenses --------78.11%2.49M78.11%2.49M--2.35M--1.74M----0.29%1.4M0.29%1.4M----
Current liabilities 131.50%6.14M66.18%4.1M7.40%4.24M7.40%4.24M173.26%10.02M4.20%2.65M1.85%2.47M46.65%3.95M46.65%3.95M35.33%3.67M
Non current liabilities
-Long term debt 157.51%891K150.79%948K84.71%290K84.71%290K94.67%323K80.12%346K36.64%378K-56.51%157K-56.51%157K-62.46%165.92K
Non current accrued expenses 93.01%1.44M62.86%1.37M-0.77%647K-0.77%647K-0.23%752K-10.56%744K-7.76%840K-33.20%652K-33.20%652K-24.64%753.71K
Total non current liabilities 41.44%13.76M23.01%11.78M3.92%11.26M3.92%11.26M61.62%17.07M2.75%9.73M1.55%9.58M10.75%10.83M10.75%10.83M6.89%10.56M
Shareholders'equity
Share capital 5.11%434.55M5.64%432.51M6.65%430.91M6.65%430.91M7.73%428.83M4.19%413.42M3.26%409.41M3.24%404.04M3.24%404.04M1.76%398.07M
-common stock 5.11%434.55M5.64%432.51M6.65%430.91M6.65%430.91M7.73%428.83M4.19%413.42M3.26%409.41M3.24%404.04M3.24%404.04M1.76%398.07M
Additional paid-in capital 6.94%43.2M5.75%42.69M5.16%42.12M5.16%42.12M5.82%41.59M4.09%40.39M16.18%40.37M17.24%40.05M17.24%40.05M18.43%39.3M
Gains losses not affecting retained earnings 30.32%722K1.67%670K-17.82%544K-17.82%544K-9.36%655K22.23%554K93.41%659K70.62%662K70.62%662K77.79%722.63K
Total equity 0.32%32.07M-1.64%34.75M3.98%38.82M3.98%38.82M18.30%46.09M-20.56%31.97M-20.52%35.33M-18.63%37.33M-18.63%37.33M-25.92%38.96M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg